311 related articles for article (PubMed ID: 22607124)
1. Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support.
Loforte A; Violini R; Musumeci F
J Card Surg; 2012 Jul; 27(4):528-9. PubMed ID: 22607124
[TBL] [Abstract][Full Text] [Related]
2. Bailout transcatheter closure of patent foramen ovale for refractory hypoxaemia after left ventricular assist device implantation.
Fischer Q; Kirsch M; Brochet E; Juliard JM
Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):246-8. PubMed ID: 25912477
[TBL] [Abstract][Full Text] [Related]
3. Successful interventional closure of a patent foramen ovale in a pediatric patient supported with a biventricular assist device.
Loeffelbein F; Schlensak C; Beyersdorf F; Dittrich S
Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):778-9. PubMed ID: 17768144
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD.
Bartoli CR; McCants KC; Birks EJ; Flaherty MP; Slaughter MS
J Invasive Cardiol; 2013 Mar; 25(3):154-6. PubMed ID: 23468448
[TBL] [Abstract][Full Text] [Related]
5. A change of heart: reopening of a foramen ovale.
Pai VB; Vallurupalli S; Kasula SR; Hakeem A; Bhatti S
Can J Cardiol; 2014 Oct; 30(10):1250.e17-8. PubMed ID: 25108496
[TBL] [Abstract][Full Text] [Related]
6. Amplatzer™ occlusion device implantation in a patient with biventricular HeartWare®.
Arif R; Ruhparwar A; Kallenbach K; Weymann A; Schmack B; Karck M; Gorenflo M
Int J Artif Organs; 2014 Jan; 37(1):93-5. PubMed ID: 24634338
[TBL] [Abstract][Full Text] [Related]
7. Hypoxemia complicating LVAD insertion: novel application of the Amplatzer PFO occlusion device.
Srinivas CV; Collins N; Borger MA; Horlick E; Murphy PM
J Card Surg; 2007; 22(2):156-8. PubMed ID: 17338756
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
Price MJ
Interv Cardiol Clin; 2017 Oct; 6(4):555-567. PubMed ID: 28886846
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
10. Hypoxemia in the setting of right to left shunting through patent foramen ovale without pulmonary hypertension.
Miller R; Khan M; Rajpurohit N; Stys A
S D Med; 2014 Jun; 67(6):225-7, 229. PubMed ID: 24979982
[TBL] [Abstract][Full Text] [Related]
11. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
12. Patent Foramen Ovale Closure for Hypoxemia.
Tobis JM; Narasimha D; Abudayyeh I
Interv Cardiol Clin; 2017 Oct; 6(4):547-554. PubMed ID: 28886845
[TBL] [Abstract][Full Text] [Related]
13. Delayed intracardial shunting and hypoxemia after massive pulmonary embolism in a patient with a biventricular assist device.
Weig T; Dolch ME; Frey L; Bruegger D; Boekstegers P; Sodian R; Irlbeck M
J Cardiothorac Surg; 2011 Oct; 6():133. PubMed ID: 21989045
[TBL] [Abstract][Full Text] [Related]
14. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review.
Blanche C; Noble S; Roffi M; Testuz A; Müller H; Meyer P; Bonvini JM; Bonvini RF
Eur J Intern Med; 2013 Dec; 24(8):813-7. PubMed ID: 24007641
[TBL] [Abstract][Full Text] [Related]
15. Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.
Kransdorf EP; Kransdorf LN; Fortuin FD; Sweeney JP; Wilansky S
Tex Heart Inst J; 2016 Apr; 43(2):171-4. PubMed ID: 27127438
[TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale-related complications in left ventricular assist device patients: a reappraisal for cardiovascular professionals.
Bacich D; Fiorencis A; Braggion G; Zuin M; Rigatelli G
J Artif Organs; 2020 Jun; 23(2):98-104. PubMed ID: 31463532
[TBL] [Abstract][Full Text] [Related]
17. Delayed perforation of a transcatheter patent foramen ovale occluder 10 years after implantation.
Vitanova K; Cleuziou J; Vogt M; Nöbauer C; Schreiber C; Lange R; Voss B
Ann Thorac Surg; 2015 Feb; 99(2):700-1. PubMed ID: 25639414
[TBL] [Abstract][Full Text] [Related]
18. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
Scacciatella P; Biava LM; Marra S
Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
